Metabolomic analysis and mass spectrometry imaging after neonatal stroke and cell therapies in mouse brains
Abstract Ischemic brain injury provokes complex, time-dependent downstream pathways that ultimately lead to cell death. We aimed to demonstrate the levels of a wide range of metabolites in brain lysates and their on-tissue distribution following neonatal stroke and cell therapies. Postnatal day 12 m...
Enregistré dans:
Auteurs principaux: | Emi Tanaka, Yuko Ogawa, Ritsuko Fujii, Tomomi Shimonaka, Yoshiaki Sato, Takashi Hamazaki, Tokiko Nagamura-Inoue, Haruo Shintaku, Masahiro Tsuji |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/642301be6d594791aaff0e5f015b232c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Serum Metabolomics of Tick-Borne Encephalitis Based on Orbitrap-Mass Spectrometry
par: Zhang M, et autres
Publié: (2021) -
Ion identity molecular networking for mass spectrometry-based metabolomics in the GNPS environment
par: Robin Schmid, et autres
Publié: (2021) -
Metabolic Profile of C-Prenyl Coumarins Using Mass Spectrometry-Based Metabolomics
par: Yan Cheng, et autres
Publié: (2021) -
Sub-nanoliter metabolomics via mass spectrometry to characterize volume-limited samples
par: Yafeng Li, et autres
Publié: (2020) -
Breath and plasma metabolomics to assess inflammation in acute stroke
par: Waqar Ahmed, et autres
Publié: (2021)